| 27413712 |
Tackling ALK in non-small cell lung cancer: the role of novel inhibitors
Bria, E,
Graziano, P,
Rossi, G,
Novello, S,
Di Maio, M,
Tiseo, M,
Facchinetti, F
|
Transl Lung Cancer Res |
2016 |
| 31943796 |
Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non-small cell lung cancer
Uchibori, K,
Yanagitani, N,
Tsukahara, M,
Okubo, K,
Nishio, M,
Seto, Y,
Okada, K,
Takahashi, K,
Oh-Hara, T,
Uematsu, S,
Fujita, N,
Katayama, R
|
Thorac Cancer |
2020 |
| 29455642 |
Role and targeting of anaplastic lymphoma kinase in cancer
Troiani, T,
Viscardi, G,
Morgillo, F,
Fasano, M,
Martinelli, E,
Ciardiello, F,
Della Corte, CM,
Di Liello, R
|
Mol. Cancer |
2018 |
| 29650534 |
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer
Mino-Kenudson, M,
Friboulet, L,
Benes, CH,
Engelman, JA,
Yoda, S,
Gainor, JF,
Dardaei, L,
Iafrate, AJ,
Heist, RS,
Shaw, AT,
Dagogo-Jack, I,
Langenbucher, A,
Burke, BJ,
Hata, AN,
Ferris, LA,
Timonina, D,
Johnson, TW,
Hubbeling, H,
Timofeevski, S,
Lawrence, MS,
Kattermann, KE,
Lin, JJ,
Prutisto-Chang, K,
Riley, AK,
Lennerz, JK
|
Cancer Discov |
2018 |
